http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-505161-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbdc68ca0aa38fef2d059853ef2b31e6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 1998-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4280919d3d390e1bfb80dff204087dc2 |
| publicationDate | 2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-505161-A |
| titleOfInvention | Synthetic linear amino acid constructs which support epitopes of antigens |
| abstract | Described are synthetic constructs comprising a linear core chain having two or more side chains pending directly from different points on the linear core chain. Each of the side chains comprises an epitopic site of an antigen or a peptide. The synthetic constructs are monomeric units that can be linked together or polymerised to form a polymer. In this feature the epitopic sites of the side chains may be the same or different. The linear core chain may be a linear sequence of amino acids having two or more of the same peptide pending directly from different points on the linear sequence. Another aspect concerns a support having one or more of the aforementioned synthetic constructs or polymers coupled thereto. Another embodiment is directed to antibodies raised against the synthetic constructs or polymers. The antibodies can be purified using the aforementioned supports. Also described is a vaccine comprising the aforementioned synthetic constructs. Methods for synthesizing the constructs and polymers are also included. In Fig.1, a monomer (100) is depicted having a linear core chain (102) with side chains (104) pending therefrom. Functional group X and functional group Y are related in that they are capable of reacting with one another to form a covalent bond and thereby link two or more monomers to form a polymer (120) as depicted in Fig. 2. The functional groups may be selected from those described above, e.g., in conjunction with the definition of a monomer. The monomers may be the same or different. When the monomers are different, the differences can reside in the composition of linear core chain (102) or side chains (104), or both. |
| priorityDate | 1997-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.